Abstract:In recent years, the role of intestinal homeostasis in health has received increasing interest, significantly improving our understanding of the complex pathophysiological interactions of the gut with other organs. Microbiota dysbiosis, impaired intestinal barrier, and aberrant intestinal immunity appear to contribute to the pathogenesis of immune-related chronic kidney diseases (CKD). Meanwhile, the relationship between the pathological changes in the respiratory tract (e.g., infection, fibrosis, granuloma) and immune-related CKD cannot be ignored. The present review aimed to elucidate the new underlying mechanism of immune-related CKD. The lungs may affect kidney function through intestinal mediation. Communication is believed to exist between the gut and lung microbiota across long physiological distances. Following the inhalation of various pathogenic factors (e.g., particulate matter 2.5 mum or less in diameter, pathogen) in the air through the mouth and nose, considering the anatomical connection between the nasopharynx and lungs, gut microbiome regulates oxidative stress and inflammatory states in the lungs and kidneys. Meanwhile, the intestine participates in the differentiation of T cells and promotes the migration of various immune cells to specific organs. This better explain the occurrence and progression of CKD caused by upper respiratory tract precursor infection and suggests the relationship between the lungs and kidney complications in some autoimmune diseases (e.g., anti-neutrophil cytoplasm antibodies -associated vasculitis, systemic lupus erythematosus). CKD can also affect the progression of lung diseases (e.g., acute respiratory distress syndrome and chronic obstructive pulmonary disease). We conclude that damage to the gut barrier appears to contribute to the development of immune-related CKD through gut-lung-kidney interplay, leading us to establish the gut-lung-kidney axis hypothesis. Further, we discuss possible therapeutic interventions and targets. For example, using prebiotics, probiotics, and laxatives (e.g., Rhubarb officinale) to regulate the gut ecology to alleviate oxidative stress, as well as improve the local immune system of the intestine and immune communication with the lungs and kidneys.

Impaired systemic proteostasis and peripheral immune cell dysfunction in kidney diseases

Advancements in understanding the mechanisms of lung-kidney crosstalk

Oxidative stress, defective proteostasis and immunometabolic complications in critically ill patients

The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older

Immunosenescence, Gut Dysbiosis, and Chronic Kidney Disease: Interplay and Implications for Clinical Management

Immunology of Kidney Disease

Kidney-Immune System Crosstalk in AKI

Kidney Disease and Proteomics: A Recent Overview of a Useful Tool for Improving Early Diagnosis

Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay between Innate and Adaptive Immune Dysfunction

Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease

Molecular Mechanisms of Kidney Injury and Repair

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma

Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases

Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease

Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage

The Diseased Kidney: Aging and Senescent Immunology

The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease

Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities